Recent VRAX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/26/2026 11:33:06 AM
- Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes • PR Newswire (US) • 05/26/2026 11:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/22/2026 08:25:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 03:14:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/14/2026 12:43:45 PM
- Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders • PR Newswire (US) • 04/14/2026 11:34:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/10/2026 08:15:02 PM
- Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation • PR Newswire (US) • 03/31/2026 11:34:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 09:01:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/31/2025 09:59:31 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 12/18/2025 09:06:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/04/2025 09:07:11 PM
- Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement • PR Newswire (US) • 12/04/2025 09:05:00 PM
- Virax Biolabs Group Limited Announces $5 Million Private Placement • PR Newswire (US) • 12/03/2025 06:53:00 PM
- Virax Biolabs soars as company advances diagnostics for post-infection syndromes • IH Market News • 12/03/2025 02:45:18 PM
- Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders • PR Newswire (US) • 12/03/2025 12:34:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/02/2025 09:42:09 PM
- Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes • PR Newswire (US) • 11/03/2025 01:29:00 PM
